Bacteria are said to increase the risk of cancer, while researchers like to use them as drugs. One study showed promising results.
- A new approach from Switzerland could be Cancer therapy revolutionizes.
- The company develops therapy in bacteria to be used as a cure for cancer.
- On study should start in early 2021.
Kassel – diagnosis Krebs: For many, this is a horror scenario, as cancer is often associated with radiation and therapies with strong side effects. Hope for Cancer drugs Home Switzerland wants to revolutionize cancer therapy and relies on an unusually sound option: bacteria.
Bacteria as a remedy against KrebsThat sounds all but reasonable, because they are considered a danger to them health. Some bacteria are even suspected of causing cancer. Helicobacter pylori infection, for example, is thought to be a risk factor for stomach cancer, according to a study published by the German Cancer Society.
Bacteria increase the risk of cancer – now they need to cure the disease
But others bacteria can risk one Cancer increase. Chlamydia is suspected of promoting cervical and ovarian cancer. Bacteria can also increase the risk of prostate cancer or colon cancer.
For your new Cancer therapy Scientists from the Swiss start-up T3 Pharmaceutical AG (T3 Pharma) want to use the bacterium “Yersinia enterocolitica”. After Campylobacter and Salmonella, this is the third most common bacterial pathogen registered in Germany in connection with intestinal diseases, the Bavarian State Institute for Health and Food Safety said.
New cancer therapy – a start-up company wants to inject bacteria into patients
In the coming years the company plans to start making bacteria injected into the patient. “Live bacteria can be the next big wave Active ingredients for cancer “, Says Simon Itig, founder of T3 Pharma, Wirtschaftswoche magazine. The idea is not entirely new: One study has been researching since 2010 whether bacteria can be used in cancer therapy.
Starting in Basel is one of the many young companies that love this new one A form of cancer therapy put it into practice now. In doing so, they live bacteria used to beat the focus of cancer. Using live bacteria gives scientists the ability to transport proteins into cancer cells and infect them, a process known as the type 3 secretion system.
A Revolution in Cancer Therapy: Better Chances of Recovery and Possible Less Side Effects
This new one Cancer therapy is very promising because it can cure cancer better than previously available therapies. In addition, this approach may have significantly fewer side effects than established therapies because bacteria would attack cancer foci from within.
The “bacterial vehicle” developed is designed to multiply in tumors as they are killed by the immune system in healthy tissue, according to T3 Pharma. purpose of Cancer therapy be it “to activate the patient’s immune system in order to fight the tumor itself.”
Bacteria as medicine – A revolution in cancer therapy
The novel Cancer therapy could soon make an important step forward. In July 2020, the company received 25 million francs (approximately 23 million euros) from investors to advance a clinical trial for its leading therapeutic candidate, T3P-Y058-739. The start of the study is planned for the beginning of 2021. Cancer patients need to be extra careful during a coronary pandemic. (Sarah Neumeier)